V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011351 | 280006236 | 0 | 102 | Neo-adjuvant (N) | 2017-12-26 | 2018-01-25 | CARBOPLATIN + GEMCITABINE | null | null | 280029642 | CISPLATIN + PACLITAXEL |
| 280011352 | 280006239 | 0 | 74 | Curative (C) | 2018-11-15 | 2018-11-20 | VIDE | 02 | N | 280029656 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011353 | 280006247 | null | 56.2 | Palliative (P) | 2014-03-13 | 2014-07-01 | PEMBROLIZUMAB | N | N | 280029686 | PEMBROLIZUMAB |
| 280011354 | 280006251 | null | null | null | 2018-01-03 | 2018-01-13 | Pemetrexed | N | N | 280029691 | VIDE |
| 280011355 | 280006254 | 1.73 | null | Disease modification (D) | 2018-01-04 | 2018-06-06 | VIDE | 02 | N | 280029694 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011356 | 280006259 | 0 | null | null | 2018-04-15 | 2018-05-10 | IVADo | N | N | 280029707 | IFOSFAMIDE + VINCRISTINE |
| 280011357 | 280006267 | 1.77 | 52.1 | Palliative (P) | 2016-04-16 | 2016-05-14 | CAPECITABINE + OXALIPLATIN | 02 | N | 280029727 | HCX |
| 280011358 | 280011943 | 1.63 | 47 | Palliative (P) | 2017-07-09 | 2017-08-13 | CHOP R - 21 days | 2 | N | 280029733 | CETUXIMAB + IRINOTECAN + MDG |
| 280011359 | 280009280 | 1.63 | 68.4 | Palliative (P) | null | 2018-06-23 | Capecitabine + Oxaliplatin 21day | N | N | 280029753 | DACTINOMYCIN + VINCRISTINE |
| 280011360 | 280006273 | 1.75 | 56.3 | Palliative (P) | 2016-12-03 | 2016-12-03 | LANREOTIDE | N | N | 280029773 | IVADO |
| 280011361 | 280009284 | 1.75 | 82.95 | Palliative (P) | 2017-06-16 | 2018-02-09 | CYCLOPHOSPHAMIDE + VINORELBINE | null | null | 280029779 | THALIDOMIDE |
| 280011362 | 280006278 | null | 68.4 | Neo-adjuvant (N) | null | 2019-04-01 | GemCarbo Days 1+8 | N | N | 280029781 | CAPECITABINE + OXALIPLATIN |
| 280011363 | 280006282 | 1.77 | 108 | Palliative (P) | 2016-05-19 | 2016-11-11 | CASPS TRIAL | N | N | 280029782 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011364 | 280011426 | 1.7 | 73.2 | Palliative (P) | 2016-04-15 | 2018-05-09 | Gemcitabine + Capecitabine | 2 | N | 280029813 | RITUXIMAB |
| 280011365 | 280006297 | 1.81 | 79.5 | Curative (C) | 2017-09-28 | 2017-09-28 | NIVOLUMAB | 2 | N | 280029826 | PAZOPANIB |
| 280011366 | 280006299 | null | 79.75 | Palliative (P) | 2015-07-05 | 2015-07-06 | Carboplatin + Liposomal Doxorubicin | 02 | N | 280029832 | IVADO |
| 280011367 | 280006302 | 1.72 | 98.55 | Adjuvant (A) | null | 2018-04-29 | EpSSG NRSTS 2005 | null | N | 280029852 | IVADO |
| 280011368 | 280006303 | 1.77 | null | Palliative (P) | 2016-06-30 | 2017-10-05 | Cisplatin + Doxorubicin | 02 | N | 280029854 | RITUXIMAB |
| 280011369 | 280009299 | 1.75 | 47.7 | Palliative (P) | 2018-03-23 | 2018-03-30 | STS Rhabdo VIT0910 Vinc Irinotecan | Y | N | 280029855 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011370 | 280006309 | null | 56.3 | Palliative (P) | 2019-10-15 | 2019-10-27 | ABVD | N | N | 280029884 | FLUOROURACIL + MITOMYCIN + RT |
| 280011371 | 280006313 | 1.64 | 86.6 | Palliative (P) | 2014-12-15 | 2014-12-27 | Cyclophosphamide + Topotecan | 2 | N | 280029896 | CARBOPLATIN + CETUXIMAB |
| 280011372 | 280006320 | 1.72 | 89.2 | Palliative (P) | 2019-04-26 | 2019-05-21 | Dox + HD Mtx (post PAM) | N | N | 280029953 | LIPOSOMAL DOXORUBICIN |
| 280011373 | 280006325 | 1.81 | 65.5 | Palliative (P) | 2016-11-22 | 2016-12-20 | BLEOMYCIN + VINCRISTINE | 2 | N | 280029968 | CISPLATIN + FLUOROURACIL + RT |
| 280011374 | 280006328 | 1.73 | 57.4 | Palliative (P) | 2018-03-06 | 2018-03-11 | LIPOSOMAL DOXORUBICIN | N | Y | 280029973 | KESTREL TRIAL |
| 280011375 | 280011433 | 1.65 | 63.1 | Palliative (P) | 2014-08-31 | 2014-09-09 | CAPECITABINE + CARBOPLATIN + Cetuximab | null | Y | 280029985 | IVADO |
| 280011376 | 280006331 | 1.74 | 76.3 | Palliative (P) | 2015-09-05 | 2015-09-12 | IPILIMUMAB + NIVOLUMAB | 2 | Y | 280029988 | METHOTREXATE INTRATHECAL |
| 280011377 | 280006333 | 1.64 | 70.6 | Palliative (P) | 2018-02-16 | 2018-10-11 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 2 | N | 280030002 | LIPOSOMAL DOXORUBICIN |
| 280011378 | 280006335 | 1.8 | 56.7 | Neo-adjuvant (N) | 2014-06-23 | 2014-06-27 | CYCLOPHOSPHAMIDE + MTX | N | N | 280030003 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280011379 | 280006341 | null | 49 | Curative (C) | 2018-05-16 | 2018-06-12 | KESTREL Trial | Y | N | 280030024 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011380 | 280006346 | 1.8 | 45 | Curative (C) | 2017-08-09 | 2018-02-24 | STS Rhabdo rel BERNIE Vinor Cyclo | 02 | N | 280030037 | DOXORUBICIN + GEMCITABINE |
| 280011381 | 280006348 | 1.69 | 41.5 | Adjuvant (A) | 2015-11-18 | 2015-11-26 | CREATE TRIAL | 02 | N | 280030045 | CVP R |
| 280011382 | 280009324 | null | 167 | Curative (C) | 2018-12-18 | 2018-12-24 | ECX | N | N | 280030055 | VIDE |
| 280011383 | 280006358 | 1.69 | null | Curative (C) | 2017-03-16 | 2017-04-30 | VIDE | 01 | null | 280030059 | CMV |
| 280011384 | 280006359 | 1.82 | 86 | Palliative (P) | 2017-04-03 | 2018-01-16 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 280030067 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280011385 | 280006363 | 1.7 | 99.9 | Palliative (P) | 2017-08-04 | 2017-09-24 | Bevacizumab 7.5mg/kg | N | N | 280030068 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280011386 | 280011439 | 1.67 | 77.05 | Palliative (P) | null | 2018-12-07 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 2 | N | 280030070 | IVADO |
| 280011387 | 280009331 | 1.58 | null | null | 2017-08-29 | 2017-09-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | 280030073 | CARBOPLATIN + CETUXIMAB + FU |
| 280011389 | 280010753 | 1.6 | 74.3 | Curative (C) | 2016-07-12 | 2016-07-13 | IDELALISIB | N | null | 280030118 | CISPLATIN + FLUOROURACIL + RT |
| 280011390 | 280006381 | 1.8 | 87.7 | Curative (C) | 2019-04-02 | 2019-04-17 | GemCarbo Days 1+8 | 2 | N | 280030124 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011391 | 280006382 | 1.7 | 65.6 | Palliative (P) | 2017-04-18 | 2017-05-09 | CAPECITABINE + TEMOZOLOMIDE | 2 | N | 280030134 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280011392 | 280006390 | 1.57 | 100.5 | Palliative (P) | 2016-02-21 | 2016-03-05 | Carboplatin + Cetux + FU (>Cycle 2) | N | Y | 280030163 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280011393 | 280006395 | 1.87 | 167 | Curative (C) | 2018-03-26 | 2018-04-03 | BLEOMYCIN + VINCRISTINE | N | N | 280030164 | VIDE |
| 280011394 | 280006397 | 1.65 | null | Palliative (P) | 2018-09-23 | 2018-10-07 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280030165 | BUSULFAN + MELPHALAN |
| 280011395 | 280006399 | 1.85 | 88.3 | null | 2018-05-27 | 2018-06-10 | Irinotecan 14day | 2 | N | 280030167 | VIDE |
| 280011396 | 280009346 | 1.85 | 77.05 | Palliative (P) | 2019-05-28 | 2019-06-25 | Carboplatin + Liposomal Doxorubicin | null | N | 280030174 | DACTINOMYCIN + VINCRISTINE |
| 280011397 | 280009349 | 1.81 | null | Disease modification (D) | null | 2016-01-24 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 280030187 | CARBO + FLUOROURACIL |
| 280011398 | 280006408 | 1.79 | 103.7 | Curative (C) | 2015-11-02 | 2015-11-12 | CARBOPLATIN + VINORELBINE | N | Y | 280030189 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280011399 | 280006411 | null | 83.95 | Palliative (P) | 2016-06-10 | 2017-01-13 | Docetaxel 75mg/m2 (21 day) | null | null | 280030190 | IVADO |
| 280011400 | 280006415 | 1.56 | 89.8 | Palliative (P) | 2017-04-21 | 2017-06-27 | NIVOLUMAB | 02 | N | 280030196 | BENDAMUSTINE + RITUXIMAB |
| 280011401 | 280009355 | 1.9 | 77.8 | Curative (C) | 2010-09-19 | 2014-04-14 | BCG Intravesical | N | N | 280030215 | LIPOSOMAL DOXORUBICIN |